However, considering the PTL role in CRC prognosis, Boeckx et al. showed that patients with RAS wild-type left-sided mCRC had a better OS than right-sided disease, regardless of treatment received (Boeckx et al., 2018). This evidence concerns the gene PNLIP and colorectal carcinoma.